314 related articles for article (PubMed ID: 34813879)
41. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
42. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
43. Transdermal Drug Delivery: A Step towards Treatment of Cancer.
Kriplani P; Guarve K
Recent Pat Anticancer Drug Discov; 2022; 17(3):253-267. PubMed ID: 34856914
[TBL] [Abstract][Full Text] [Related]
44. Transdermal delivery of contraceptives.
Friend DR
Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
[TBL] [Abstract][Full Text] [Related]
45. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
Amjadi M; Mostaghaci B; Sitti M
Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
[TBL] [Abstract][Full Text] [Related]
46. [Transdermal drug delivery systems].
Foco A; Hadziabdić J; Becić F
Med Arh; 2004; 58(4):230-4. PubMed ID: 15526592
[TBL] [Abstract][Full Text] [Related]
47. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
48. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
Baviskar DT; Parik VB; Jain DJ
PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
[TBL] [Abstract][Full Text] [Related]
49. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
[TBL] [Abstract][Full Text] [Related]
50. Laser facilitates week-long sustained transdermal drug delivery at high doses.
Kakar P; Li Z; Li Y; Cao Y; Chen X
J Control Release; 2020 Mar; 319():428-437. PubMed ID: 31923535
[TBL] [Abstract][Full Text] [Related]
51. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
Panda A; Sharma PK; Narasimha Murthy S
AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
[TBL] [Abstract][Full Text] [Related]
52. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Li B; Huang G; Ma Z; Qin S
Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
[TBL] [Abstract][Full Text] [Related]
53. Current advances in the fabrication of microneedles for transdermal delivery.
Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
[TBL] [Abstract][Full Text] [Related]
54. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
[TBL] [Abstract][Full Text] [Related]
55. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
56. The use of polymers for dermal and transdermal delivery.
Valenta C; Auner BG
Eur J Pharm Biopharm; 2004 Sep; 58(2):279-89. PubMed ID: 15296955
[TBL] [Abstract][Full Text] [Related]
57. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
Goswami T; Audett J
Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
[TBL] [Abstract][Full Text] [Related]
58. Perspectives on transdermal ultrasound mediated drug delivery.
Smith NB
Int J Nanomedicine; 2007; 2(4):585-94. PubMed ID: 18203426
[TBL] [Abstract][Full Text] [Related]
59. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
60. Design and evaluation of patches for transdermal delivery of losartan potassium.
Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
